Phoenix might have hoped to benefit from the EU merger regime's "one-stop shop," which allows companies to seek a single authorization for large multinational acquisitions, but it’s likely to see the French portion of its McKesson deal handed over to the regulator in France.Even though the German pharmaceutical wholesaler only filed its